Lanean...

Drug Discovery in Academia- the third way?

As the pharmaceutical industry continues to re-strategise and focus on low-risk, relatively short term gains for the sake of survival, we need to re-invigorate the early stages of drug discovery and rebalance efforts towards novel modes of action therapeutics and neglected genetic and tropical disea...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Frearson, Julie, Wyatt, Paul
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2948567/
https://ncbi.nlm.nih.gov/pubmed/20922062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/17460441.2010.506508
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!